Literature DB >> 20027157

The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques.

Lucie Vistejnova1, Jana Dvorakova, Martina Hasova, Tomas Muthny, Vladimir Velebny, Karel Soucek, Lukas Kubala.   

Abstract

OBJECTIVES: Determination of cell numbers is a crucial step in studies focused on cytokinetics and cell toxicity. The impedance-based analysis employing electronic sensor array system xCELLigence System allowing label-free dynamic monitoring of relative viable adherent cell amounts was compared with the most utilized methods for relative quantification of viable cell numbers based on a determination of cellular metabolism.
DESIGN: Colorimetric assay based on reduction of tetrazolium salt (MTT) by mitochondrial enzymes and chemiluminiscent assay based on intracellular adenosine triphosphate (ATP) determination were compared with the impedance-based system. Cell morphology was compared by microscopic evaluation. Normal human epidermal keratinocytes (NHEK) and normal human dermal fibroblasts (NHDF), together with 3T3 mouse fibroblast and HaCaT keratinocyte cell lines were employed.
RESULTS: The progress of cell growth curves obtained by different methods during 72 hours reflected cell type and cell seeding densities. The impedance-based method was found to be applicable for the determination of the cell proliferation of 3T3 fibroblasts, HaCaT and NHDF, since the comparison of this method with ATP and MTT determinations showed a comparable results. In contrast, the proliferation of NHEK measured by the impedance-based method did not correlate with other methodological approaches. This could be accounted to the specific morphological appearance of these cells.
CONCLUSION: The study shows the impedance-based detection of viable adherent cells is a valuable approach for cytokinetics and pharmacological studies. However, the specific morphological characteristics of cell lines have to be considered employing this method for determination of cell proliferation without using other reference methods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20027157

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  17 in total

Review 1.  [Pharmacological characterization of head and neck cancer in ex-vivo tests].

Authors:  G Wichmann; A Dietz
Journal:  HNO       Date:  2011-09       Impact factor: 1.284

2.  Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.

Authors:  Capucine Van Rechem; Joshua C Black; Myriam Boukhali; Martin J Aryee; Susanne Gräslund; Wilhelm Haas; Cyril H Benes; Johnathan R Whetstine
Journal:  Cancer Discov       Date:  2015-01-06       Impact factor: 39.397

3.  A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors.

Authors:  Capucine Van Rechem; Joshua C Black; Patricia Greninger; Yang Zhao; Carlos Donado; Paul D Burrowes; Brendon Ladd; David C Christiani; Cyril H Benes; Johnathan R Whetstine
Journal:  Cancer Discov       Date:  2015-01-06       Impact factor: 39.397

4.  Dietary fatty acids specifically modulate phospholipid pattern in colon cells with distinct differentiation capacities.

Authors:  Jiřina Hofmanová; Josef Slavík; Petra Ovesná; Zuzana Tylichová; Jan Vondráček; Nicol Straková; Alena Hyršlová Vaculová; Miroslav Ciganek; Alois Kozubík; Lucie Knopfová; Jan Šmarda; Miroslav Machala
Journal:  Eur J Nutr       Date:  2016-03-16       Impact factor: 5.614

5.  β-Arrestin 1 inhibits the GTPase-activating protein function of ARHGAP21, promoting activation of RhoA following angiotensin II type 1A receptor stimulation.

Authors:  D F Anthony; Y Y Sin; S Vadrevu; N Advant; J P Day; A M Byrne; M J Lynch; G Milligan; M D Houslay; G S Baillie
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

6.  TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

Authors:  Michael K Asiedu; James N Ingle; Marshall D Behrens; Derek C Radisky; Keith L Knutson
Journal:  Cancer Res       Date:  2011-05-09       Impact factor: 12.701

7.  A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility.

Authors:  Michael J Smout; Andrew C Kotze; James S McCarthy; Alex Loukas
Journal:  PLoS Negl Trop Dis       Date:  2010-11-16

8.  Real-time monitoring of photocytotoxicity in nanoparticles-based photodynamic therapy: a model-based approach.

Authors:  Hamanou Benachour; Thierry Bastogne; Magali Toussaint; Yosra Chemli; Aymeric Sève; Céline Frochot; François Lux; Olivier Tillement; Régis Vanderesse; Muriel Barberi-Heyob
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

9.  Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.

Authors:  Luc G T Morris; Andrew M Kaufman; Yongxing Gong; Deepa Ramaswami; Logan A Walsh; Şevin Turcan; Stephanie Eng; Kasthuri Kannan; Yilong Zou; Luke Peng; Victoria E Banuchi; Phillip Paty; Zhaoshi Zeng; Efsevia Vakiani; David Solit; Bhuvanesh Singh; Ian Ganly; Linda Liau; Timothy C Cloughesy; Paul S Mischel; Ingo K Mellinghoff; Timothy A Chan
Journal:  Nat Genet       Date:  2013-01-27       Impact factor: 38.330

10.  Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM).

Authors:  Gabriel Rinaldi; Alex Loukas; Paul J Brindley; Jeff T Irelan; Michael J Smout
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-08-06       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.